Jefferies Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Jefferies Group’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$718K	Buy	40,000 +36,500	+1,043%	+$479K	0.01%	912
2022 Q2	$33.7K	Sell	3,500 -39,000	-92%	-$490K	﹤0.01%	1426
2022 Q1	$715K	Buy	+42,500	New	+$628K	﹤0.01%	958
2017 Q1	–	Sell	-17,700	Closed	-$85K	–	2730
2016 Q4	$85K	Sell	17,700 -52,000	-75%	-$1.54M	﹤0.01%	2032
2016 Q3	$3.21M	Buy	69,700 +38,800	+126%	+$2.19M	0.02%	714
2016 Q2	$1.58M	Buy	+30,900	New	+$1.54M	0.01%	971

Other funds holding ISEE

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

YCM

Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

Jefferies Group's ISEE Position: Q3 2022 in Review

Jefferies Group increased its IVERIC bio, Inc. Common Stock (ISEE) stake by 2,861% in Q3 2022, buying an estimated $247K and bringing the position to 19,510 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #1174.

Jefferies Group first reported a position in ISEE in Q2 2015 and has held it in 8 quarters since. The position peaked at $1.58M in Q2 2021. 213 funds tracked by Wall St. Rank hold ISEE as of Q3 2022.

Jefferies Group held 19,510 shares of IVERIC bio, Inc. Common Stock worth $350K as of Q3 2022.
Jefferies Group bought 18,851 IVERIC bio, Inc. Common Stock shares in Q3 2022, an estimated $247K.
IVERIC bio, Inc. Common Stock made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1174 holding.
Jefferies Group first reported a position in IVERIC bio, Inc. Common Stock in Q2 2015 and has held it in 8 quarters since.
Jefferies Group's IVERIC bio, Inc. Common Stock position peaked at $1.58M in Q2 2021.
213 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.